Summary
Updated Aug 31, 2026
Kevin Lee Freeman is Chief Commercial Officer of Health Catalyst, Inc. (HCAT). 3 SEC Form 4 filings on record going back to 2024, most recently on 3 December 2025. Most recent open-market trade: sold $67K of HCAT on 3 December 2024. Lifetime open-market sales: $67K.
Recent Transactions
4Every recent SEC Form 4 transaction Kevin Lee Freeman has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin Lee Freeman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Benjamin Landry - $21K of HCAT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Kevin Lee Freeman?
Kevin Lee Freeman is a corporate insider, tracked as Chief Commercial Officer of Health Catalyst, Inc. (HCAT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kevin Lee Freeman last file a Form 4?
The most recent primary Form 4 on record is dated 3 December 2025, one of 3 filings going back to 2024.
Has Kevin Lee Freeman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($67K) across all tracked filings.
Where can I see all of Kevin Lee Freeman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Kevin Lee Freeman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
